"Muscle Weakness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
- Muscle Weakness
- Muscle Weaknesses
- Weakness, Muscle
- Weaknesses, Muscle
- Muscular Weakness
- Muscular Weaknesses
- Weakness, Muscular
- Weaknesses, Muscular
Below are MeSH descriptors whose meaning is more general than "Muscle Weakness".
Below are MeSH descriptors whose meaning is more specific than "Muscle Weakness".
This graph shows the total number of publications written about "Muscle Weakness" by people in this website by year, and whether "Muscle Weakness" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Muscle Weakness" by people in Profiles.
Restoration of Sarcoplasmic Reticulum Ca2+ ATPase (SERCA) Activity Prevents Age-Related Muscle Atrophy and Weakness in Mice. Int J Mol Sci. 2020 Dec 22; 22(1).
Surgical Treatment of Tethered Cord Syndrome in Adults: A Systematic Review and Meta-Analysis. World Neurosurg. 2020 05; 137:e221-e241.
Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness. Redox Biol. 2019 01; 20:68-74.
Oxidative stress-induced dysregulation of excitation-contraction coupling contributes to muscle weakness. J Cachexia Sarcopenia Muscle. 2018 10; 9(5):1003-1017.
Shifts in EMG spectral power during fatiguing dynamic contractions. Muscle Nerve. 2014 Jul; 50(1):95-102.
Decompressive hemicraniectomy in pediatric patients with malignant middle cerebral artery infarction: case series and review of the literature. World Neurosurg. 2013 Jul-Aug; 80(1-2):126-33.
Novel GNE mutations in two phenotypically distinct HIBM2 patients. Neuromuscul Disord. 2011 Feb; 21(2):102-5.
Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease. J Neuroophthalmol. 2010 Jun; 30(2):165-6.
Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum Mol Genet. 2007 Apr 15; 16(8):919-28.
Clinical problem-solving. Still consider the source. N Engl J Med. 2005 Oct 06; 353(14):1503-7.